Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Income towards Parent Company: 2011-2025

Historic Income towards Parent Company for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to -$883,820.

  • Sunshine Biopharma's Income towards Parent Company rose 26.21% to -$883,820 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 41.81%. This contributed to the annual value of -$5.1 million for FY2024, which is 13.94% down from last year.
  • Latest data reveals that Sunshine Biopharma reported Income towards Parent Company of -$883,820 as of Q3 2025, which was up 50.09% from -$1.8 million recorded in Q2 2025.
  • Sunshine Biopharma's Income towards Parent Company's 5-year high stood at $667,116 during Q4 2021, with a 5-year trough of -$23.5 million in Q4 2022.
  • Its 3-year average for Income towards Parent Company is -$1.2 million, with a median of -$1.2 million in 2024.
  • Examining YoY changes over the last 5 years, Sunshine Biopharma's Income towards Parent Company showed a top increase of 161.55% in 2021 and a maximum decrease of 6,461.84% in 2021.
  • Sunshine Biopharma's Income towards Parent Company (Quarterly) stood at $667,116 in 2021, then plummeted by 3,624.47% to -$23.5 million in 2022, then spiked by 94.68% to -$1.3 million in 2023, then plummeted by 72.65% to -$2.2 million in 2024, then increased by 26.21% to -$883,820 in 2025.
  • Its Income towards Parent Company was -$883,820 in Q3 2025, compared to -$1.8 million in Q2 2025 and -$1.2 million in Q1 2025.